Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients

BACKGROUND: Serum Prostate-specific antigen (PSA) has been used for screening and diagnosis of prostate cancer (PCa) but it is burdened by its low accuracy, creating a need for reliable diagnostic markers. Despite prostate-specific membrane antigen (PSMA) and prostate stem cell antigen (PSCA) being...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Mustafa M, Abdel Hamid, Fatma F, Abdelgawad, Iman, Ismail, Abeer, Malash, Ibrahim, Ibrahim, Doaa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152839/
https://www.ncbi.nlm.nih.gov/pubmed/36708571
http://dx.doi.org/10.31557/APJCP.2023.24.1.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152839/
https://www.ncbi.nlm.nih.gov/pubmed/36708571
http://dx.doi.org/10.31557/APJCP.2023.24.1.223

Ejemplares similares